ThinkSabio

$APVO

$1.92▲ +2.1% YTD

5 SEC 13D/G filings tracked · Last updated Sep 24, 2026

Filing History
News
APVO ▲ +2.1% - Aptevo Therapeutics Inc.
CP $1.92▲ +2.1%Sep 24, 2026 · ThinkSabio Blog

$APVO - Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development…

News
APVO ▼ -12.7% - Aptevo Therapeutics Inc.
CP $2.26▲ -12.7%Sep 3, 2026 · ThinkSabio Blog

$APVO - Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML…

News
APVO ▲ +8.1% - Aptevo Therapeutics Inc.
CP $2.53▲ +8.1%Sep 2, 2026 · ThinkSabio Blog

$APVO vol…

News
APVO ▲ +8.1% - Aptevo Therapeutics Inc.
CP $2.53▲ +8.1%Sep 2, 2026 · ThinkSabio Blog

$APVO patent news…

SEC 13D/G
$APVO SEC Filing Update (22-JUN-2026) | ThinkSabio - Stocks Simplified
$4.71▼ -49.84%Jun 22, 2026 · ThinkSabio Blog

SEC Filing Update: #APVO : $4.71 Sector: Healthcare | YTD: 🔽 -49.84% The SEC disclosed Today (22-JUN-2026) that NIOWAVE, INC. has Newly bought 151,723…